Long‐term safety and efficacy of rIX‐FP prophylaxis with extended dosing intervals up to 21 days in adults/adolescents with hemophilia B
- Resource Type
- Article
- Source
- In
Journal of Thrombosis and Haemostasis May 2020 18(5):1065-1074 - Subject
- Language
- ISSN
- 1538-7836